The increase in the price target from $13 to $15 suggests a slightly more optimistic view on UiPath's future performance, which could positively influence investor sentiment and potentially lead to a short-term price increase. However, the Neutral rating indicates that the analyst does not see significant upside potential, which tempers the impact.